All News

Regulatory & Standards

Phacilitate’s ATE Round-Up: People, Patients, and Possibilities
12 September 2022
Phacilitate’s ATE Round-Up: People, Patients, and Possibilities
In this blog we take
Phacilitate’s ATE Plenary: Celebrating Science and Stripes
2 September 2022
Phacilitate’s ATE Plenary: Celebrating Science and Stripes
In this blog, we round-up
bluebird bio’s Zynteglo Approved by the FDA for Beta-Thalassemia
24 August 2022
bluebird bio’s Zynteglo Approved by the FDA for Beta-Thalassemia
bluebird bio has announced that
Fujifilm Invests $1.6 Billion into Expanding its Cell Culture Manufacturing Services
1 July 2022
Fujifilm Invests $1.6 Billion into Expanding its Cell Culture Manufacturing Services
Fujifilm Corporation has announced a
POPULAR NEWS ITEMS
Image
22 September 2022

CAR-T Manufacturing Challenges and How to Overcome Them

Image
22 September 2022

Lentiviral Vector Manufacture and Testing: Challenges and Solutions

Image
22 September 2022

Looking to the Future of CAR-T Cell Therapy Manufacture

Market Access and Reimbursement Q&A with AviadoBio CEO Lisa Deschamps
21 June 2022
Market Access and Reimbursement Q&A with AviadoBio CEO Lisa Deschamps
Lisa Deschamps, AviadoBio CEO and
Market Access and Reimbursement Q&A with Nicola Redfern
21 June 2022
Market Access and Reimbursement Q&A with Nicola Redfern
Phacilitate's Advanced Therapies Europe speaker
Market Access and Reimbursement Q&A with Vice President of Novartis, Tay Salimullah
21 June 2022
Market Access and Reimbursement Q&A with Vice President of Novartis, Tay Salimullah
Two bluebird bio Gene Therapies Achieve Unanimous FDA Support
16 June 2022
Two bluebird bio Gene Therapies Achieve Unanimous FDA Support
Bluebird bio celebrates a big
Load more News
RECOMENDED TOPICS
Clinical Trials
Collaborations, Mergers & Acquisitions
Finance & Investment
Patient Access & Engagement
Regulatory & Standards
Reimbursement
Strategy
POPULAR NEWS ITEMS
Image

CAR-T Manufacturing Challenges and How to Overcome Them

Image

Lentiviral Vector Manufacture and Testing: Challenges and Solutions

Image

Looking to the Future of CAR-T Cell Therapy Manufacture